Theranostics in nuclear medicine practice
A Yordanova, E Eppard, S Kürpig… - OncoTargets and …, 2017 - Taylor & Francis
The importance of personalized medicine has been growing, mainly due to a more urgent
need to avoid unnecessary and expensive treatments. In nuclear medicine, the theranostic …
need to avoid unnecessary and expensive treatments. In nuclear medicine, the theranostic …
Chromogranin A—biological function and clinical utility in neuro endocrine tumor disease
IM Modlin, BI Gustafsson, SF Moss, M Pavel… - Annals of surgical …, 2010 - Springer
Abstract Background Neuroendocrine tumors (NETs) are a form of cancer that differ from
other neoplasia in that they synthesize, store, and secrete peptides, eg, chromogranin A …
other neoplasia in that they synthesize, store, and secrete peptides, eg, chromogranin A …
Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer: American College of Chest …
Background These guidelines are an update of the evidence-based recommendations for
follow-up and surveillance of patients after curative-intent therapy for lung cancer. Particular …
follow-up and surveillance of patients after curative-intent therapy for lung cancer. Particular …
Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a heterogeneous group of
neoplasms that arise from cells of the diffuse neuroendocrine system and are characterized …
neoplasms that arise from cells of the diffuse neuroendocrine system and are characterized …
The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors
B Lawrence, BI Gustafsson, M Kidd… - Endocrinology and …, 2011 - endo.theclinics.com
An accurate tumor marker is a critical tool in tumor management because it establishes an
uncertain diagnosis, offers a basis for individual prognostication, signals response to …
uncertain diagnosis, offers a basis for individual prognostication, signals response to …
Neuroendocrine carcinomas of the gastroenteropancreatic system: a comprehensive review
EE Ilett, SW Langer, IH Olsen, B Federspiel, A Kjær… - Diagnostics, 2015 - mdpi.com
To date, empirical literature has generally been considered lacking in relation to
neuroendocrine carcinomas (NECs), the highly malignant subgroup of neuroendocrine …
neuroendocrine carcinomas (NECs), the highly malignant subgroup of neuroendocrine …
[HTML][HTML] Merkel cell carcinoma
JC Becker - Annals of Oncology, 2010 - Elsevier
Merkel cell carcinoma (MCC) is a highly aggressive neuroendocrine carcinoma of the skin.
The incidence of this rare tumor is increasing rapidly; the American Cancer Society …
The incidence of this rare tumor is increasing rapidly; the American Cancer Society …
[HTML][HTML] Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron …
CM Korse, BG Taal, A Vincent… - European journal of …, 2012 - Elsevier
BACKGROUND: Chromogranin A (CgA) is the most important tumour marker for well-
differentiated neuroendocrine tumours (NET) and neuron specific enolase (NSE) for poorly …
differentiated neuroendocrine tumours (NET) and neuron specific enolase (NSE) for poorly …
Chromogranin A: from laboratory to clinical aspects of patients with neuroendocrine tumors
P Di Giacinto, F Rota, L Rizza… - International Journal …, 2018 - Wiley Online Library
Background. Neuroendocrine tumors (NETs) are characterized by having behavior and
prognosis that depend upon tumor histology, primary site, staging, and proliferative index …
prognosis that depend upon tumor histology, primary site, staging, and proliferative index …
Chromogranin A as a marker for diagnosis, treatment, and survival in patients with gastroenteropancreatic neuroendocrine neoplasm
Y Wang, Q Yang, Y Lin, L Xue, M Chen, J Chen - Medicine, 2014 - journals.lww.com
Chromogranin A (CgA) not only plays an important role in pathologic diagnosis, but is also
used as a circulating biomarker in patients with gastroenteropancreatic neuroendocrine …
used as a circulating biomarker in patients with gastroenteropancreatic neuroendocrine …